Sign In
Buy ICCC
$10.05
+0.260 (+2.66%)
At Close: Jun 03, 2026
ImmuCell Swings to Q2 Profit on Strong Sales, Shares Still Slide
11:51am, Thursday, 21'st Aug 2025
ICCC posts Q2 profit on higher sales and margins, but shares fall as investors weigh one-time boosts and Re-Tain's delayed commercialization.
ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript
11:04am, Friday, 15'th Aug 2025
ImmuCell Corporation (NASDAQ:ICCC ) Q2 2025 Earnings Conference Call August 15, 2025 9:00 AM ET Company Participants Michael F. Brigham - President, CEO, Treasurer, Secretary & Director Timothy C.
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025
04:05pm, Thursday, 14'th Aug 2025
PORTLAND, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Announces Bank Debt Refinancing
04:05pm, Tuesday, 12'th Aug 2025
PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025
08:00am, Thursday, 07'th Aug 2025
PORTLAND, Maine, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside
12:56pm, Tuesday, 22'nd Jul 2025
ICCC earns "Outperform" rating with record Q1 sales, margin gains and growth potential tied to Re-Tain's FDA progress and new product formats.
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025
08:00am, Wednesday, 09'th Jul 2025
PORTLAND, Maine, July 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Embarks on CEO Succession Planning Process
08:00am, Wednesday, 25'th Jun 2025
PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
06:30am, Thursday, 05'th Jun 2025
PORTLAND, Maine, June 05, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin Gains
12:41pm, Monday, 19'th May 2025
ICCC posts record Q1 sales, returns to earnings and expands margins y/y as First Defense demand grows and production issues subside.
ImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript
10:19am, Thursday, 15'th May 2025
ImmuCell Corporation (NASDAQ:ICCC ) Q1 2025 Earnings Conference Call May 15, 2025 9:00 AM ET Company Participants Joe Diaz - Managing Partner, Lytham Partners, LLC Michael Brigham - President & Chief
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025
04:05pm, Wednesday, 14'th May 2025
PORTLAND, Maine, May 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets sc
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025
08:42am, Monday, 12'th May 2025
PORTLAND, Maine, May 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets sc
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025
04:05pm, Tuesday, 08'th Apr 2025
PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
04:05pm, Wednesday, 02'nd Apr 2025
PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
